SCHEMBL7480899

SCHEMBL7480899

CN(C)C(=O)c1nc2c([N+](=O)[O-])cccc2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKN1 Q16512 2/20 0.50
PKN2 Q16513 2/20 0.50
RAB9A P51151 2/20 0.46
NPC1 O15118 2/20 0.46
ADORA3 P0DMS8 1/20 0.45
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
ITGB3 P05106 1/20 0.41
ITGAV P06756 1/20 0.41
PDE10A Q9Y233 1/20 0.40
SMN1; SMN2 Q16637 4/20 0.40
KMT2A Q03164 2/20 0.39
HTT P42858 1/20 0.39
HPGD P15428 1/20 0.39
NOS1 P29475 1/20 0.38
APEX1 P27695 1/20 0.38
GSTP1 P09211 1/20 0.38
GSTM2 P28161 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8277810 0.85 PKN1 (0.53) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL8601951 0.83 PKN1 (0.55) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL8598655 0.82 PKN1 (0.53) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL28458039 0.78 PKN1 (0.47) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL28467668 0.77 PKN1 (0.49) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL7970694 0.77 CHEK1 (0.48) PKN1PKN2GAAITGB3ITGAV
SCHEMBL7966716 0.77 PKN1 (0.55) PKN1PKN2RAB9ANPC1ADORA3
SCHEMBL1013588 0.76 PKN1 (0.60) PKN1PKN2NPC1ADORA3MGAM
SCHEMBL7478700 0.76 KDM4E (0.54) PKN1PKN2HPGDPARP1
SCHEMBL603318 0.75 HRH4 (0.69) PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
EP-0946519-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-06 EP disclosed
WO-1998024771-A1 BENZAMIDE DERIVATIVES HAVING A VASOPRESSIN ANTAGONISTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-06-11 WO disclosed